-
Event / Presentation
2025.10.14
CHITOSE to Attend CPHI Frankfurt and BIO-Europe 2025 to Forge New Biopharmaceutical Partnerships
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
Event / Presentation
2025.05.14
CHITOSE Presented on CHO-MK Cells Establishment and Culture Strategy at Cell Culture Engineering XIX
-
Event / Presentation
2025.01.27
CEO Tomohiro Fujita Presented at the 19th Saudi-Japanese Business Council Meeting
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
-
Event / Presentation
2024.09.20
Members of the Royal Government of Bhutan Toured CHITOSE Group Research Facilities
-
CHITOSE Group Announces Capital Raising of JPY 500 Million from NSK ltd. and Conclusion of Business Alliance Agreement
-
Event / Presentation
2024.09.10
CHITOSE Delivered a Presentation on CHO-MK at Biologics Manufacturing Korea 2024
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
-
Event / Presentation
2024.07.16
CHITOSE Presents Advanced Mammalian Cell Solutions at the 28th ESACT Meeting 2024, in Edinburgh, Scotland
